Theoretical Models to Explain the Association of HLA-B27 with Ankylosing Spondylitis

References

• Popper Karl. Objective knowledge—An evolutionary approach. Clarendon Press, Oxford 1972
   Google Scholar
• Breur-Vriesendorp B S, Huis B, Dekker A J, Breuning M H, Ivanyi P. Subtypes of antigen HLA-B27 (B27W and B27K) defined by cytotoxic lymphocytes: Identification of a third subtype (B27C) prevalent in Oriental populations. The spondyloarthropathies, M Ziff, S B Cohen. Raven Press, New York 1985; 9: 55–65, Advances Inflammation Res
   Google Scholar
• Rojo S, Lopez, De Castro J A, Aparicio P. HLA-B27 antigenicity: Antibodies against the chemically synthesized 63-84 peptide from HLA-B27.1, display alloantigenic specificity and discriminate among HLA-B27 subtypes. J Immunol 1986; 137: 904–10
   Google Scholar
• Turek P J, Grumet F C, Engleman EG. Molecular variants of the HLA-B27 antigen in healthy individuals and patients with spondyloarthropathies. Immunological Rev 1985; 86: 71–91
   Google Scholar
• Khan MA. Ankylosing spondylitis and heterogeneity of HLA-B27. Sem in Arthritis Rheum 1988; 18: 134–41
   Google Scholar
• Ebringer A, Baines M, Childerstone M, Ghuloom M, Ptaszynska T. Etiopathogenesis of ankylosing spondylitis and the cross-tolerance hypothesis. The spondyloarthropathies, M Ziff, S B Cohen. Raven Press, New York 1985; 9: 101–28, Advances Inflam Res
   Google Scholar
• Moll J MH. Diagnostic criteria and their evaluation. Ankylosing spondylitis, JMH Moll. Churchill Livingstone, London 1980; 137–50
   Google Scholar
• Linssen A, Dekker-Saeys A J, Dandrieu M R, Christiaans B J, Baarsma G S, Tjoa S T, De Jong P TUM, Kijlstra A, Feltkamp T EW. Possible ankylosing spondylitis in acute anterior uveitis. Br J Rheum 1983; 22: 137–43, Suppl 2
   Google Scholar
• Van der Linden S M, Valkenburg H A, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum 1984; 27: 361–68
   PubMed Web of Science ®Google Scholar
• Brewerton D. Introduction: B27-associated diseases, In this issue.
   Google Scholar
• Ball J. Pathology and pathogenesis. Ankylosing spondylitis, JMH Moll. Churchill Livingstone, Edinburgh 1980; 96–112
   Google Scholar
• Veys E M, van Laere M. Serum IgG, IgM and IgA levels in ankylosing spondylitis. Ann Rheum Dis 1973; 32: 493–6
   PubMed Web of Science ®Google Scholar
• Kinsella T D, Espinosa L, Vasey F. Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis. J Rheumatol 1975; 2: 308–13
   PubMed Web of Science ®Google Scholar
• Cowling P, Ebringer R, Ebringer A. Association of inflammation with raised serum IgA in ankylosing spondylitis. Ann Rheum Dis 1980; 39: 545–9
   PubMed Web of Science ®Google Scholar
• Aho K, Ahvonen P, Lassus A, Sievers K, Tiilikainen A. HLA 27 in reactive arthritis. Lancet 1973; ii: 157
   Google Scholar
• Toivanen A, Tertti R, Lahesmaa-Rantala R, Stahlberg T H, Granfors K. Factors associated with the development of reactive arthritis. Br J Rheum 1988; 27: 46–51, Suppl II
   Google Scholar
• Ivanyi P. B27 Transgenic mice and disease. In this issue.
   Google Scholar
• Nickerson P, Hogen K L, Luthra H S, David C. Effect of H2 genes on expression of HLA-B27 and yersinia-induced arthritis. In this issue.
   Google Scholar
• Taurog in Discussion reported by L. P. de Waal. 6(In this issue.)12
   Google Scholar
• Woodrow J C, Nichol F E, Whitehouse GH. Genetic studies in ankylosing spondylitis. Br J Rheum 1983; 22: 12–17, Suppl 2
   Google Scholar
• Khan MA. Genetics of HLA-B27. Br J Rheum 1988; 27: 6–11, Suppl II
   Google Scholar
• Ebringer A. The relationship between Klebsiella infection and ankylosing spondylitis. The gut and rheumatic disease, P J Rooney. Balliere's Clinical Rheumatology. 1989; 3: 321–38
   Google Scholar
• Linssen A. B27+ disease versus B27- disease. In this issue.
   Google Scholar
• Leirisalo M, Skylv G, Kousa M, Voipio-Pulkki L-M, Suoranta H, Nissiia M, Hvidmar L, Damm Nielsen E, Svejgaard A, Tiilikainen A, Laitinen O. Follow-up study on patients with Reiter's disease and reactive arthritis with special reference to HLA-B27. Arthritis Rheum 1982; 25: 249–58
   PubMed Web of Science ®Google Scholar
• van Bohemen C HG, Grumet F C, Zanen HC. Identification of HLA-B27M1 and M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia. Immunology 1984; 52: 607–9
   PubMed Web of Science ®Google Scholar
• Kinsella TD. Review of research on the role of Klebsiella antigens in the spondyloarthropathies. The spondyloarthropathies, M Ziff, S B Cohen. Raven Press, New York 1985; 9: 139–49, Advances Inflam Res
   Google Scholar
• Ebringer A, Cowling P, Ngwa Suh N, James D CO, Ebringer RW. Cross-reactivity between Klebsiella aerogenes species and B27 lymphocyte antigens as an aetiological factor in ankylosing spondylitis. INSERM (Paris) 1976; 58: 27
   Google Scholar
• Ebringer R, Cooke D, Cawdell D R, Cowling P, Ebringer A. Ankylosing spondylitis: Klebsiella and HLA-B27. Rheum Rehab 1977; 16: 190–6
   PubMedGoogle Scholar
• Ebringer R W, Cawdell D R, Cowling P, Ebringer A. Sequential studies in ankylosing spondylitis: Association of Klebsiella pneumoniae with active disease. Ann Rheum Dis 1978; 37: 146–51
   PubMed Web of Science ®Google Scholar
• Hunter T, Harding G KM, Kaprove R E, Schroeder ML. Fecal carriage of various Klebsiella and Enterobacter species in patients with active ankylosing spondylitis. Arthritis Rheum 1981; 24: 106–8
   PubMedGoogle Scholar
• Kuberski T T, Morse H G, Rate R G, Bonnell MD. Increased recovery of Klebsiella from the gastrointestinal tract to Reiter's syndrome and ankylosing spondylitis patients. Br J Rheum 1983; 22: 85–90, Suppl 2
   Google Scholar
• Brewerton DA. Ankylosing spondylitis and acute anterior uveitis: A quest for infective agents. The spondyloarthropathies, M Ziff, S B Cohen. Raven Press, New York 1985; 9: 151–5, Adv Inflam Res
   Google Scholar
• Trull A, Ebringer R, Panayi G S, Colthorpe D, James D CO, Ebringer A. IgA antibodies in ankylosing spondylitis. Scand J Rheum 1983; 12: 249–53
   PubMed Web of Science ®Google Scholar
• Trull A K, Ebringer A, Panayi G S, Ebringer R, James D CO. HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis. Clin Exp Immunol 1984; 55: 74–80
   PubMed Web of Science ®Google Scholar
• Ebringer A. Ankylosing spondylitis and Klebsiella reactive arthritis. J Orthopaedic Rheum 1988; 1: 243–50
   Google Scholar
• Cooper R, Fraser S M, Sturrock R D, Gemmell CG. Raised titres of anti-Klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis and inflammatory bowel disease. Br Med J 1988; 296: 1432–4
   PubMedGoogle Scholar
• Lahesmaa R, Skurnik M, Granfors T, Mottonen T, Saario R, Toivanen A, Toivanen P. A tetrapeptide shared by Yersinia outer membrane protein Yopl and HLA-B27. In this issue
   Google Scholar
• McDevitt H O, Bodmer WF. HAL, immune response genes and disease. Lancet 1974; i: 1269–75
   Google Scholar
• Bodmer WF. The HLA system and disease. J Royal Coll Phys Lond 1980; 14: 43–50
   PubMedGoogle Scholar
• Ebringer A. The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis. Br J Rheum 1983; 22: 53–66, Suppl 2
   PubMedGoogle Scholar
• Welsh J, Avakian H, Cowling P, Ebringer A, Wooley P, Panayi G, Ebringer R. Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera. Br J Exp Pathol 1980; 61: 85–91
   PubMedGoogle Scholar
• Avakian H, Welsh J, Ebringer A, Entwistle CC. Ankylosing spondylitis, HLA-B27 and Klebsiella. II. Cross-reactivity studies with human tissue typing sera. Br J Exp Pathol 1980; 61: 92–6
   PubMedGoogle Scholar
• Bohemen C G, van Alpen L, Zanen O G, Dekker-Saeys A J, Zanen HC. Antibodies against cell envelope antigens of Yersinia enterocolitica in reactive arthritis and ankylosing spondylitis. Br J Rheumatol 1983; 22: 83–4, Suppl 2
   Google Scholar
• Kono D H, Ogasawara M, Effros R B, Park M S, Waldord R L, Yu D TY. Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria. Clin Exp Immunol 1985; 61: 503–8
   PubMed Web of Science ®Google Scholar
• Schwimmbeck P L, Yu D TY, Oldston M BA. Autoantibodies to HLA-B27 in the sera of HLA-B27 patients with ankylosing spondylitis and Reiter's syndrome: molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 1987; 166: 173–81
   PubMed Web of Science ®Google Scholar
• Ivanyi P. Dysfunction of HLA-B27. In this issue.
   Google Scholar
• Yu D TY. Molecular mimicry: fact or fiction. Br J Rheum 1988; 27: 55–7, Suppl II
   Google Scholar
• Seager K, Bashir H V, Geczy A F, Edmonds J P, De-Vere Tyndall A. Evidence for a specific B27-associated cell surface marker on lymphocytes of patients with ankylosing spondylitis. Nature 1979; 277: 68–70
   PubMed Web of Science ®Google Scholar
• Edmonds J, Geczy A F, Sullivan J S, Prendergast J K, Upfold L I, Bashir HV. Enteric bacteria and HLA-B27 associated cell surface modification in patients with seronegative spondarthritis. Br J Rheum 1983; 22: 75–82, Suppl 2
   PubMedGoogle Scholar
• Beukelman C J, van Leeuwen A, Aerts P C, van Kregten E, van Bree S, van Rood J J, Willers M N, van Dijk H. Rabbit antisera to Enterobacteriaceae isolated from HLA-B27 positive patients with ankylosing spondylitis are lytic for the mononuclear cells of AS patients. Br J Rheum 1988; 27: 58–60, Suppl II
   Google Scholar
• Beukelman C J, van Quarles, Ufford H C, van Bree F PMJ, Aerts P C, Nieuwenhoff C, Reerink G, van Leeuwen A, van Dijk H. Trial and error in producing ankylosing-spondylitis-selective antisera according to Andrew Geczy. In this issue.
   Google Scholar
• Toubert A, Philippon A, Amor B. HLA-B27, ankylosing spondylitis and Klebsiella pneumoniae toward a molecular approach. J Rheumatol 1987; 14: 391–3
   Google Scholar
• Archer J R, Stubbs M M, Geczy AF. Factors influencing the cytotoxicity of anti-bacterial sera for lymphocytes from ankylosing spondylitis patients. Clin Exp Rheum 1988; 6: 35–9
   PubMedGoogle Scholar
• Repo H, Leirisalo M, Kosunen T U. Neutrophil chemotaxis under agarose: a statistical analysis and comparison of the chemotactic response of cells from different donors. J Immunol Methods 1981; 46: 227–42
   Google Scholar
• Repo H, Leirisalo M, Koivuranta P, Osterman T, Kiistala U, Gahmberg C G, Vapaatalo H, Tiilikainen A, Laitinen O. Neutrophil function and HLA-B27. Br J Rheum 1983; 22: 168–171, Suppl 2
   Google Scholar
• Pease C T, Fordham J N, Currey H LF. Polymorphonuclear cell motility, ankylosing spondylitis and HLA-B27. Ann Rheum Dis 1984; 43: 279–84
   PubMed Web of Science ®Google Scholar
• Leirisalo-Repo M. Inflammation in HLA-B27 associated diseases. In this issue.
   Google Scholar
• Zinkernagel R M, Doherty PC. H-2 compatibility requirement for T-cell mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J Exp Med 1975; 141: 1427–36
   PubMed Web of Science ®Google Scholar
• Bjorkman P J, Saper M A, Samraoui B, Bennett W S, Strominger J L, Wiley DC. Structure of the human class I histocompatibility antigen: HLA-A2. Nature 1987; 329: 506–12
   PubMed Web of Science ®Google Scholar
• Benjamin R, Parham P. Guilt by association; HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11: 137–42
   PubMedGoogle Scholar
• Parham P. Structure of Class-I MHC Molecules: HLA-B27 and disease. In this issue.
   Google Scholar
• López, De Castro J A, Bragado R, Lauzurica P, López D, Rojo S. Structure and immune recognition of HLA-B27 antigens: implications for disease association. In this issue.
   Google Scholar
• Raybourne R B, Williams K M, Cheng X K, Yu D TY. Demonstration of shared epitopes between bacterial proteins and HLA-class I proteins using monoclonal antibodies. In this issue.
   Google Scholar